Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBX1 pseudogene 2 (RBX1P2) is a non-coding genomic sequence with high similarity to the RBX1 gene, located on a different chromosome. Pseudogenes like RBX1P2 do not encode functional proteins but may regulate gene expression of their parental gene via competition for RNA binding proteins or by acting as RNA decoys[4]. There is no evidence of RBX1P2 having a direct biological, therapeutic, or disease role, nor being a canonical biomarker or drug target. The parental gene, RBX1 (Ring-box protein 1), is an essential core subunit of multi-protein E3 ubiquitin ligase complexes (such as SCF), and plays crucial roles in protein ubiquitination, cell cycle progression, cancer proliferation, and prognosis[1][2][6]. If information is needed about a therapeutic target or receptor, refer to RBX1 instead of its pseudogene derivative, RBX1P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBX1 pseudogene 2 (RBX1P2).